Filing Details
- Accession Number:
- 0000950170-24-112387
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-03 16:29:23
- Reporting Period:
- 2024-10-01
- Accepted Time:
- 2024-10-03 16:29:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1816736 | Disc Medicine Inc. | IRON | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1778739 | Richard William White | C/O Disc Medicine, Inc. 321 Arsenal Street, Suite 101 Watertown MA 02472 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-10-01 | 201 | $9.86 | 201 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-10-01 | 32 | $49.03 | 169 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-10-01 | 40 | $50.45 | 129 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-10-01 | 50 | $51.51 | 79 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-10-01 | 79 | $52.53 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-10-01 | 201 | $0.00 | 201 | $9.86 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,206 | 2031-09-13 | No | 4 | M | Direct |
Footnotes
- The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.80 to $49.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.01 to $50.99, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.06 to $52.035, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.185 to $52.84, inclusive.
- The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.